OKYO Pharma Limited
OKYO
$2.37
$0.041.72%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | 1.86M | 1.86M | 561.70K | 561.70K | 1.69M |
| Gross Profit | -1.86M | -1.86M | -561.70K | -561.70K | -1.69M |
| SG&A Expenses | -- | -- | -- | -- | -- |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.88M | 1.88M | 1.67M | 1.67M | 3.51M |
| Operating Income | -1.88M | -1.88M | -1.67M | -1.67M | -3.51M |
| Income Before Tax | -1.94M | -1.94M | -2.05M | -2.05M | -4.03M |
| Income Tax Expenses | -923.00K | -923.00K | -708.90K | -708.90K | -30.20K |
| Earnings from Continuing Operations | -1.01M | -1.01M | -1.34M | -1.34M | -4.00M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.01M | -1.01M | -1.34M | -1.34M | -4.00M |
| EBIT | -1.88M | -1.88M | -1.67M | -1.67M | -3.51M |
| EBITDA | -1.88M | -1.88M | -1.67M | -1.67M | -3.51M |
| EPS Basic | -0.02 | -0.02 | -0.04 | -0.04 | -0.12 |
| Normalized Basic EPS | -0.03 | -0.03 | -0.04 | -0.04 | -0.08 |
| EPS Diluted | -0.02 | -0.02 | -0.04 | -0.04 | -0.12 |
| Normalized Diluted EPS | -0.03 | -0.03 | -0.04 | -0.04 | -0.08 |
| Average Basic Shares Outstanding | 45.40M | 45.40M | 33.57M | 33.57M | 32.97M |
| Average Diluted Shares Outstanding | 45.40M | 45.40M | 33.57M | 33.57M | 32.97M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |